Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Non-Current Assets: 2020-2025

Historic Non-Current Assets for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Sep 2025 value amounting to $6.5 million.

  • Insight Molecular Diagnostics' Non-Current Assets fell 90.08% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 90.08%. This contributed to the annual value of $6.3 million for FY2024, which is 16.34% up from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Non-Current Assets of $6.5 million as of Q3 2025, which was down 2.79% from $6.7 million recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Non-Current Assets registered a high of $127.4 million during Q2 2021, and its lowest value of $5.4 million during Q4 2023.
  • In the last 3 years, Insight Molecular Diagnostics' Non-Current Assets had a median value of $35.8 million in 2024 and averaged $35.8 million.
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Non-Current Assets soared by 183.02% in 2021, and later tumbled by 92.71% in 2023.
  • Over the past 5 years, Insight Molecular Diagnostics' Non-Current Assets (Quarterly) stood at $120.4 million in 2021, then plummeted by 38.09% to $74.6 million in 2022, then plummeted by 92.71% to $5.4 million in 2023, then rose by 16.34% to $6.3 million in 2024, then slumped by 90.08% to $6.5 million in 2025.
  • Its Non-Current Assets stands at $6.5 million for Q3 2025, versus $6.7 million for Q2 2025 and $7.2 million for Q1 2025.